[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Broad claims covering delivery of therapeutics using engineered bacteria. Synthetic biology tools emerging in just the last few years have made this possible. The trick, of course, is precise control. If I … Continue reading “Bacteria to Do Our Bidding”
Author: Matthew O'Donnell
Hold On To Your Brightest Young People, Michigan
I don’t have five pithy things to tell entrepreneurs in Michigan, but I do have one comment based on my 16 years in Ann Arbor trying to help commercialize biotech/medtech innovations at the University of Michigan. Do everything possible to keep your young in Michigan. The three research universities in Michigan, U-M, Michigan State University, … Continue reading “Hold On To Your Brightest Young People, Michigan”
Can Molecular Medicine Survive Its Teenage Years, and Reach its Potential This Decade?
As the 21st century approaches its teenage years, so too does molecular medicine. Discovery of the structure of DNA more than 50 years ago launched the field of molecular biology. During the last decade, we have seen the first translation of some fundamental discoveries in this field into medical tools. Clearly, however, we are early … Continue reading “Can Molecular Medicine Survive Its Teenage Years, and Reach its Potential This Decade?”